Related Experiment Videos
Extracorporeal membrane oxygenation for cardiac support
1Heartlink ECMO Centre, Department of Cardiothoracic Surgery, Glenfield Hospital, Leicester, UK.
Coronary Artery Disease
|June 1, 1997
Summary
Extracorporeal membrane oxygenation (ECMO) offers vital support for critically ill children with heart issues. Despite controversy in some groups, ECMO shows remarkable survival rates for pediatric cardiac insufficiency.
Area of Science:
- Pediatric critical care medicine
- Cardiopulmonary bypass technology
- Extracorporeal life support
Background:
- Extracorporeal membrane oxygenation (ECMO) provides extended cardiac or respiratory support in intensive care units.
- While ECMO is established for neonatal respiratory failure, its application in adults and children remains debated.
- This review focuses on ECMO's role in pediatric cardiac insufficiency.
Purpose of the Study:
- To review the application of ECMO in pediatric patients experiencing pre- and post-operative cardiac insufficiency.
- To evaluate the efficacy and survival rates of ECMO in this specific pediatric population.
Main Methods:
- Review of existing literature and clinical data on ECMO use in pediatric cardiac insufficiency.
- Analysis of survival outcomes in patients treated with ECMO for cardiac conditions.
Main Results:
- ECMO demonstrates significant survival rates, ranging from 43% to 61%, in pediatric patients with cardiac insufficiency.
- These survival rates are notable given the typically critical condition of these patients before ECMO initiation.
Conclusions:
- ECMO is a valuable, life-sustaining intervention for pediatric patients with severe cardiac insufficiency.
- The remarkable survival rates support the continued use and investigation of ECMO in pediatric cardiac critical care.